Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. van Denventer, S. J. H. (2001). Transmembrane TNFα, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's Disease. Gastroenterology, 121, 1242–1246.
2. Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G. R., Tesser, J., et al. (2003). Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis & Rheumatism, 48, 927–934.
3. Mohan, A. K., Cote, T. R., Block, J. A., Manadan, A. M., Siegel, J., & Braun, M. M. (2004). Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clinical Infectious Diseases, 39, 295–299.
4. Wallis, R. S., Broder, M. S., Wong, J. Y., Hanson, M. E., & Beenhouwer, D. O. (2004). Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clinical Infectious Diseases, 38, 1261–1265.
5. Wallis, R. S., Saliu, O. Y., Sofer, C., Stein, D. S., & Schwander, S. K. (2005). Differential effects of TNF blockers on TB immunity. Annals of the Rheumatic Diseases, 64(suppl 3), 132.
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献